<unk>  (overutilization, overuse, or overtreatment) is<unk>  care provided with a higher volume or cost than is appropriate. In the United States, where<unk>  care costs are the highest as a percentage of GDP, overuse was the predominant factor in its expense, accounting for about a third of its<unk>  care spending ($750 billion out of $2.6 trillion) in 2012. Factors that drive overuse include paying<unk>  professionals more to do more (fee-for-service), defensive medicine to protect against litigiousness, and insulation from price sensitivity in instances where the consumer is not the payer—the patient receives goods and services but insurance pays for them (whether public insurance, private, or both). Such factors leave many actors in the system (doctors, patients, pharmaceutical companies, device manufacturers) with inadequate incentive to restrain<unk>  care prices or overuse. This drives payers, such as national<unk>  insurance systems or the U.S. Centers for Medicare and Medicaid Services, to focus on medical necessity as a condition for payment. However, the threshold between necessity and lack thereof can often be subjective. Overtreatment, in the strict sense, may refer to<unk>  medical interventions, including treatment of a self-limited condition (overdiagnosis) or to extensive treatment for a condition that requires only limited treatment. It is economically linked with overmedicalization.
Unnecessary health care
Drug disposal
Futile medical care
Medication costs
Consumer import of prescription drugs
Personal medicine
Public security
Urban legends about drugs